EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gender differences in tumor characteristics, treatment allocation and survival in stage I–III pancreatic cancer: a nationwide study

A M Gehrels, A D Wagner, M G Besselink, R H A Verhoeven, C H J van Eijck, H W M van Laarhoven, J W Wilmink, L G van der Geest, Dutch Pancreatic Cancer Group

European Journal of Cancer · 2024-07 · 206 · 114117

DOI: 10.1016/j.ejca.2024.114117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2024-07. Verfasst von A M Gehrels und 8 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatmen…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Sex and gender are modulators of health and disease and may have impact on treatment allocation and survival in patients with cancer. In this study, we analyzed the impact of sex and gender on treatment allocation and overall survival in patients with stage I-III pancreatic cancer. METHODS: Patients with stage I-III pancreatic cancer diagnosed between 2015 and 2020 were selected from the nationwide Netherlands Cancer Registry. Associations between sex and gender and the probability of receiving surgical and/or systemic treatment were examined with multivariable logistic regression analyses. Overall survival was assessed with log rank test and multivariable Cox proportional hazard analysis. RESULTS: Among 6855 patients, 51.2 % were female. Multivariable logistic regression analyses with adjustment for known confounders (age, performance status, comorbidities, tumor location, tumor stage and previous malignancies) showed that females less often received systemic chemotherapy compared to males (OR 0.799, 95 %CI 0.703-0.909, p < .001). No difference was found in the probability for undergoing surgical resection. Furthermore, females had worse overall survival compared to males (median OS 8.5 and 9.2 months respectively, 95 %CI 8.669-9.731). CONCLUSION: This nationwide study found that female patients with stage I-III pancreatic cancer significantly less often received systemic treatment and had worse overall survival as compared to males. Disparities in pancreatic cancer care can be decreased by recognizing and resolving potential obstacles or biases in treatment decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeoplasm StagingHumansFemaleMaleAgedMiddle AgedNetherlandsSex FactorsRegistriesHealthcare DisparitiesAged, 80 and overSurvival Rate

Stichwörter der Autor:innen

Gender identityLocalized pancreatic cancerPancreatic neoplasmsSexSurgical resectionSystemic treatment

Autor:innen und Institutionen

  • Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands. Electronic address:…
  • Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands; Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
  • Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands; Department of Resea…
  • Department of Surgery, Erasmus MC Cancer Institute, Erasmus University Rotterdam, Rotterdam, the Netherlands.
  • Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.

Zitieren

APA

Gehrels, A. M., Wagner, A. D., Besselink, M. G., Verhoeven, R. H. A., van Eijck, C. H. J., van Laarhoven, H. W. M., Wilmink, J. W., van der Geest, L. G., & Dutch Pancreatic Cancer Group (2024). Gender differences in tumor characteristics, treatment allocation and survival in stage I–III pancreatic cancer: a nationwide study. European Journal of Cancer, 206, 114117. https://doi.org/10.1016/j.ejca.2024.114117

Vancouver

Gehrels AM, Wagner AD, Besselink MG, Verhoeven RHA, van Eijck CHJ, van Laarhoven HWM, et al. Gender differences in tumor characteristics, treatment allocation and survival in stage I–III pancreatic cancer: a nationwide study. European Journal of Cancer. 2024;206:114117. doi:10.1016/j.ejca.2024.114117

BibTeX
@article{Gehrels2024,
  author = {Gehrels, A M and Wagner, A D and Besselink, M G and Verhoeven, R H A and van Eijck, C H J and van Laarhoven, H W M and Wilmink, J W and van der Geest, L G and Dutch Pancreatic Cancer Group, Dutch Pancreatic Cancer Group},
  title = {Gender differences in tumor characteristics, treatment allocation and survival in stage I–III pancreatic cancer: a nationwide study},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {206},
  pages = {114117},
  doi = {10.1016/j.ejca.2024.114117}
}
Kostenlos starten →